DOI: 10.1055/s-00035024

Thrombosis and Haemostasis


Medicine USNLo.
Study to gather information about the proper dosing of the oral FXIa inhibitor BAY 2433334 and to compare the safety of the study drug to apixaban, a non-vitamin K oral anticoagulant (NOAC) in patients with irregular heartbeat (atrial fibrillation) that can lead to heart-related complications. (PACIFIC-AF).
2020 . Available at: . Accessed January 14, 2020

Download Bibliographical Data

Search in: